--- title: "Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin +… | Magellan" description: "Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield) — Osteo Bi-Flex Triple Strength is an oral joint-health supplement whose principal…" url: "https://magellanlongevity.com/p/217.md" canonical: "https://magellanlongevity.com/p/217.html" html: "https://magellanlongevity.com/p/217.html" type: "product" section: "Nutraceuticals & Cellular Energizers" evidence_grade: "Moderate evidence" evidence_tier: "moderate" citations: 22 product_id: 217 price_usd: 13.79 updated: 2026-09-02 author: "Gabriel Radu, DO" author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765." publisher: "Magellan Longevity" content_format: "markdown" license: "Educational content — not medical advice" --- # Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield) [Home](https://magellanlongevity.com/) › [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) › Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield) **HTML version:** https://magellanlongevity.com/p/217.html · **In the Magellan app:** https://magellanlongevity.com/#/product/217 ## Key facts | Field | Value | | --- | --- | | Product | Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield) | | Category | [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) | | Evidence grade | Moderate evidence (B) | | Peer-reviewed citations | 22 | | Typical listed price | $13.79 (check the live price) | | Where to buy | [Search Amazon](https://www.amazon.com/s?k=Osteo%20Bi-Flex%20Triple%20Strength%20%28Glucosamine%20Chondroitin%20%2B%20Joint%20Shield%29&tag=magellanlong-20) | | Catalog ID | 217 | ## What it is Osteo Bi-Flex Triple Strength is an oral joint-health supplement whose principal ingredients are glucosamine and chondroitin sulfate, two natural constituents of cartilage. Glucosamine is a building block for the glycosaminoglycans that make up cartilage, and chondroitin sulfate contributes to cartilage's resistance to compression; both are marketed to support joint comfort and function in osteoarthritis. They are sold together as dietary supplements in the United States and, in some countries, as prescription symptomatic slow-acting drugs for osteoarthritis (SYSADOAs). Glucosamine is available as either glucosamine sulfate or glucosamine hydrochloride, a distinction that appears to matter in clinical studies. ## Its role in longevity Evidence on glucosamine and chondroitin for osteoarthritis is large but genuinely mixed. The pivotal NIH-funded GAIT trial and several network meta-analyses found no clinically meaningful benefit over placebo in the overall population, whereas the MOVES trial reported the combination was as effective as celecoxib for severe knee pain, recent meta-analyses report modest symptom benefits, and 3-year trials of glucosamine sulfate suggest it may slow joint-space narrowing. A small randomized crossover trial found the combination lowered the inflammatory marker CRP by about 23% versus placebo. Both agents are consistently reported as safe and well tolerated. Large observational cohorts link regular glucosamine use to lower all-cause and cardiovascular mortality and fewer cardiovascular events, but a published 2022 analysis argues these associations reflect healthy-user selection bias, so they are hypothesis-generating, not proof of lifespan benefit. This evidence describes the glucosamine and chondroitin compounds and their formulations in general, not this specific commercial product. ## Evidence grade: Moderate evidence - **What the grade means:** Curated grade based on the human and mechanistic evidence for this compound. - **Dose used in studies:** Triple Strength provides about 1,500 mg/day glucosamine HCl plus a chondroitin/MSM complex and 100 mg/day 5-LOXIN Boswellia serrata; the key Boswellia trial (Sengupta 2008) tested 100 and 250 mg/day, standardized to 30% AKBA. - **Dose from food:** This combination isn't obtainable from a normal diet: Boswellia serrata is an herbal tree resin with no food source at all, glucosamine comes from shellfish shells, and chondroitin only from animal cartilage. - **What this grade does not say:** Genuinely mixed: the NIH GAIT trial was negative overall while the MOVES trial found the combination comparable to celecoxib, and recent meta-analyses are modestly favorable. The mortality and cardiovascular associations are observational with a published selection-bias critique — not a proven longevity benefit. Safety across trials is excellent. ## Where it comes from without a bottle Food, exercise and behaviour routes to the same pathway, each with its citation. | Natural source | How it works | Citation | | --- | --- | --- | | Bone broth & cartilage-rich cuts | Simmered bones, joints and skin release the same glucosaminoglycans and chondroitin sulfate that Osteo Bi-Flex delivers. The whole-food route is gentler but far less concentrated than the standardized supplement dose used in trials. | Annals of the Rheumatic Diseases 2015 [PMID 25589511](https://pubmed.ncbi.nlm.nih.gov/25589511/) | | Daily glucosamine-bearing foods | Shellfish shells (the source of supplemental glucosamine) and cartilage in chicken feet or oxtail supply joint-building precursors. In large cohorts, people who took glucosamine regularly even showed lower all-cause mortality. | Annals of the Rheumatic Diseases 2020 [PMID 32253185](https://pubmed.ncbi.nlm.nih.gov/32253185/) | ### What those papers actually say 1. **Bone broth & cartilage-rich cuts** Annals of the Rheumatic Diseases 2015 · [PMID 25589511](https://pubmed.ncbi.nlm.nih.gov/25589511/) · [DOI 10.1136/annrheumdis-2014-206792](https://doi.org/10.1136/annrheumdis-2014-206792) > CS+GH has comparable efficacy to celecoxib in reducing pain, stiffness, functional limitation and joint swelling/effusion after 6 months in patients with painful knee osteoarthritis 2. **Daily glucosamine-bearing foods** Annals of the Rheumatic Diseases 2020 · [PMID 32253185](https://pubmed.ncbi.nlm.nih.gov/32253185/) · [DOI 10.1136/annrheumdis-2020-217176](https://doi.org/10.1136/annrheumdis-2020-217176) > Regular glucosamine supplementation was associated with lower mortality due to all causes, cancer, CVD, respiratory and digestive diseases. ## In the news - **Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know** — NCCIH (NIH) 2023 [Read it](https://www.nccih.nih.gov/health/glucosamine-and-chondroitin-for-osteoarthritis-what-you-need-to-know) > There has been a substantial amount of research on the use of glucosamine and chondroitin, separately or together, for pain and joint function in people with knee osteoarthritis, but studies have had inconsistent results, and expert evaluations of the evidence have reached conflicting conclusions. - **Glucosamine supplements could lower risk of cardiovascular disease** — Tulane University School of Public Health 2019 [Read it](https://sph.tulane.edu/news/glucosamine-supplements-could-lower-risk-cardiovascular-disease) > The researchers found that glucosamine use was associated with a 15% lower risk of total CVD events, and a 9% to 22% lower risk of CHD, stroke, and CVD death compared with no use. - **Glucosamine, Chondroitin for Osteoarthritis Pain** — Arthritis Foundation 2022 [Read it](https://www.arthritis.org/health-wellness/treatment/complementary-therapies/supplements-and-vitamins/glucosamine-chondroitin-osteoarthritis-pain) > Although studies on glucosamine and chondroitin have been mixed, some evidence suggests they may help relieve OA joint pain and stiffness. ## The research Peer-reviewed studies on the active compound. Quotes are verbatim from the cited abstract. Research describes the active mechanism and is not a claim about this specific product. ### Cited studies 1. **Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a non-inferiority trial versus celecoxib (MOVES)** Ann Rheum Dis 2015 · [PMID 25589511](https://pubmed.ncbi.nlm.nih.gov/25589511/) · [DOI 10.1136/annrheumdis-2014-206792](https://doi.org/10.1136/annrheumdis-2014-206792) > Chondroitin sulfate plus glucosamine matched celecoxib, cutting WOMAC pain ~50% at 6 months with a good safety profile. 2. **Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis (GAIT)** N Engl J Med 2006 · [PMID 16495392](https://pubmed.ncbi.nlm.nih.gov/16495392/) · [DOI 10.1056/NEJMoa052771](https://doi.org/10.1056/NEJMoa052771) > For patients with moderate-to-severe knee pain, the glucosamine–chondroitin combination produced a significantly higher response than placebo (79.2% vs 54.3%, P=0.002). 3. **Efficacy and safety of 5-Loxin (AKBA-enriched Boswellia serrata) for osteoarthritis of the knee** Arthritis Res Ther 2008 · [PMID 18667054](https://pubmed.ncbi.nlm.nih.gov/18667054/) · [DOI 10.1186/ar2461](https://doi.org/10.1186/ar2461) > Both doses of 5-Loxin produced clinically and statistically significant improvements in osteoarthritis pain and function, with reduced cartilage-degrading MMP-3. 4. **Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials.** J Orthop Surg Res 2018 · [PMID 29980200](https://pubmed.ncbi.nlm.nih.gov/29980200/) · [DOI 10.1186/s13018-018-0871-5](https://doi.org/10.1186/s13018-018-0871-5) > Given the effectiveness of these symptomatic slow-acting drugs, oral chondroitin is more effective than placebo on relieving pain and improving physical function. 5. **Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis.** Arch Orthop Trauma Surg 2023 · [PMID 35024906](https://pubmed.ncbi.nlm.nih.gov/35024906/) · [DOI 10.1007/s00402-021-04326-9](https://doi.org/10.1007/s00402-021-04326-9) > Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent. 6. **Chondroitin for osteoarthritis.** Cochrane Database Syst Rev 2015 · [PMID 25629804](https://pubmed.ncbi.nlm.nih.gov/25629804/) · [DOI 10.1002/14651858.CD005614.pub2](https://doi.org/10.1002/14651858.CD005614.pub2) > The benefit was small to moderate with an 8 point greater improvement in pain (range 0 to 100) and a 2 point greater improvement in Lequesne's index (range 0 to 24), both seeming clinically meaningful. 7. **Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.** Lancet 2001 · [PMID 11214126](https://pubmed.ncbi.nlm.nih.gov/11214126/) · [DOI 10.1016/S0140-6736(00)03610-2](https://doi.org/10.1016/S0140-6736%2800%2903610-2) > The 106 patients on placebo had a progressive joint-space narrowing, with a mean joint-space loss after 3 years of -0.31 mm (95% CI -0.48 to -0.13). There was no significant joint-space loss in the 106 patients on glucosamine sulphate: -0.06 mm (-0.22 to 0.09). 8. **Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.** Arch Intern Med 2002 · [PMID 12374520](https://pubmed.ncbi.nlm.nih.gov/12374520/) · [DOI 10.1001/archinte.162.18.2113](https://doi.org/10.1001/archinte.162.18.2113) > Long-term treatment with glucosamine sulfate retarded the progression of knee osteoarthritis, possibly determining disease modification. 9. **Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis** JAMA 2018 · [PMID 30575881](https://pubmed.ncbi.nlm.nih.gov/30575881/) · [DOI 10.1001/jama.2018.19319](https://doi.org/10.1001/jama.2018.19319) > Associations with decreases in pain were found for glucosamine sulfate (SMD −0.29; 95% CrI −0.49 to −0.09); the association with pain improvement remained significant for glucosamine sulfate when trials at high risk of bias were excluded. 10. **Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.** BMJ 2010 · [PMID 20847017](https://pubmed.ncbi.nlm.nih.gov/20847017/) · [DOI 10.1136/bmj.c4675](https://doi.org/10.1136/bmj.c4675) > Compared with placebo, glucosamine, chondroitin, and their combination do not reduce joint pain or have an impact on narrowing of joint space. 11. **Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis** Br J Sports Med 2018 · [PMID 29018060](https://pubmed.ncbi.nlm.nih.gov/29018060/) · [DOI 10.1136/bjsports-2016-097333](https://doi.org/10.1136/bjsports-2016-097333) > Of 20 supplements investigated in 69 studies, seven demonstrated large and clinically important effects for [osteoarthritis] pain reduction at short term. 12. **Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials.** Rheumatol Int 2018 · [PMID 29947998](https://pubmed.ncbi.nlm.nih.gov/29947998/) · [DOI 10.1007/s00296-018-4077-2](https://doi.org/10.1007/s00296-018-4077-2) > Oral supplementation with glucosamine or chondroitin sulfate reduces pain in knee OA. However, there is no additional effect using both therapeutic agents in combination for the management of symptomatic knee OA. 13. **Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.** Inflammopharmacology 2024 · [PMID 38581640](https://pubmed.ncbi.nlm.nih.gov/38581640/) · [DOI 10.1007/s10787-024-01460-9](https://doi.org/10.1007/s10787-024-01460-9) > In the meta-analysis, CS showed a significant reduction in pain intensity, and improved physical function compared to the placebo; GS showed a significant reduction in tibiofemoral joint space narrowing. 14. **The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.** J Gen Intern Med 2021 · [PMID 33846938](https://pubmed.ncbi.nlm.nih.gov/33846938/) · [DOI 10.1007/s11606-021-06755-z](https://doi.org/10.1007/s11606-021-06755-z) > Glucosamine and chondroitin yielded statistically significant but clinically questionable long-term benefit on structure and symptoms, though both had favorable safety profiles. 15. **Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.** Drugs Aging 2007 · [PMID 17658908](https://pubmed.ncbi.nlm.nih.gov/17658908/) · [DOI 10.2165/00002512-200724070-00005](https://doi.org/10.2165/00002512-200724070-00005) > On the basis of the results of recent randomised controlled trials and meta-analyses, we can conclude that glucosamine sulfate (but not glucosamine hydrochloride) and chondroitin sulfate have small-to-moderate symptomatic efficacy in OA, although this is still debated. 16. **Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials.** Ann Pharmacother 2005 · [PMID 15855241](https://pubmed.ncbi.nlm.nih.gov/15855241/) · [DOI 10.1345/aph.1E576](https://doi.org/10.1345/aph.1E576) > Glucosamine sulfate was more effective than placebo in delaying structural progression in knee OA. The risk of disease progression was reduced by 54% (pooled RR 0.46; 95% CI 0.28 to 0.73; p = 0.0011). 17. **Effects of glucosamine and chondroitin sulfate supplementation in addition to resistance exercise training and manual therapy in patients with knee osteoarthritis: A randomized controlled trial.** J Pak Med Assoc 2022 · [PMID 36156542](https://pubmed.ncbi.nlm.nih.gov/36156542/) · [DOI 10.47391/JPMA.2444](https://doi.org/10.47391/JPMA.2444) > Manual therapy and resistance exercise training are effective in the management of knee osteoarthritis, however, glucosamine and chondroitin sulfate supplementation for 4 weeks showed no additional benefits. 18. **Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study** Annals of the Rheumatic Diseases 2020 · [PMID 32253185](https://pubmed.ncbi.nlm.nih.gov/32253185/) > Regular glucosamine use was associated with significantly lower all-cause, cardiovascular, cancer, respiratory and digestive mortality (all-cause HR 0.73). 19. **Glucosamine/Chondroitin and Mortality in a US NHANES Cohort** Frontiers in Pharmacology 2020 · [PMID 33219063](https://pubmed.ncbi.nlm.nih.gov/33219063/) > Glucosamine/chondroitin use was associated with reduced all-cause mortality in a nationally representative U.S. cohort. 20. **Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.** BMJ (Clinical research ed.) 2019 · [PMID 31088786](https://pubmed.ncbi.nlm.nih.gov/31088786/) > In ~466,000 UK Biobank participants, habitual glucosamine use was associated with about 15% fewer cardiovascular events and 22% lower cardiovascular death — observational, not causal. 21. **Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.** PloS one 2015 · [PMID 25719429](https://pubmed.ncbi.nlm.nih.gov/25719429/) > In a small randomized crossover trial (n=18), glucosamine plus chondroitin lowered serum CRP by 23% versus placebo, supporting an anti-inflammatory mechanism. 22. **Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies.** Pharmacoepidemiology and drug safety 2022 · [PMID 36029480](https://pubmed.ncbi.nlm.nih.gov/36029480/) > A methodological critique argues the lower mortality and cancer incidence attributed to glucosamine in observational cohorts are inflated by selection and healthy-user bias—longevity claims remain unproven. ## Where to buy [Search Amazon for Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield)](https://www.amazon.com/s?k=Osteo%20Bi-Flex%20Triple%20Strength%20%28Glucosamine%20Chondroitin%20%2B%20Joint%20Shield%29&tag=magellanlong-20) — affiliate search link. ## Structured data ```json {"@context":"https://schema.org","@graph":[{"@type":"ItemPage","@id":"https://magellanlongevity.com/p/217.html#page","url":"https://magellanlongevity.com/p/217.html","name":"Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield)","description":"Osteo Bi-Flex Triple Strength is an oral joint-health supplement whose principal ingredients are glucosamine and chondroitin sulfate, two natural…","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/p/217.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Nutraceuticals & Cellular Energizers","item":"https://magellanlongevity.com/c/1.html"},{"@type":"ListItem","position":3,"name":"Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield)","item":"https://magellanlongevity.com/p/217.html"}]},{"@type":"Product","@id":"https://magellanlongevity.com/p/217.html#product","name":"Osteo Bi-Flex Triple Strength (Glucosamine Chondroitin + Joint Shield)","category":"Nutraceuticals & Cellular Energizers","url":"https://magellanlongevity.com/p/217.html","description":"Osteo Bi-Flex Triple Strength is an oral joint-health supplement whose principal ingredients are glucosamine and chondroitin sulfate, two natural constituents of cartilage. Glucosamine is a building block for the glycosaminoglycans that make up cartilage, and chondroitin sulfate contributes to…","additionalProperty":[{"@type":"PropertyValue","name":"Evidence grade","value":"Moderate evidence"}],"offers":{"@type":"Offer","priceCurrency":"USD","price":"13.79","url":"https://www.amazon.com/s?k=Osteo%20Bi-Flex%20Triple%20Strength%20%28Glucosamine%20Chondroitin%20%2B%20Joint%20Shield%29&tag=magellanlong-20","availability":"https://schema.org/InStock"}}]} ``` ## Related on Magellan Longevity - [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md) — Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum triglycerides… - [Creatine Monohydrate](https://magellanlongevity.com/p/123.md) — Across meta-analyses and randomized trials, creatine monohydrate combined with resistance training modestly… - [Astaxanthin Softgels](https://magellanlongevity.com/p/107.md) — In humans, randomized trials and meta-analyses most consistently show that astaxanthin lowers the… - [Zinc Picolinate](https://magellanlongevity.com/p/133.md) — Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after symptom onset, can… - [Vitamin K2 (MK-7)](https://magellanlongevity.com/p/138.md) — In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating… - [All Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) - [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md) - [Longevity research map](https://magellanlongevity.com/longevity-research-map.html) ## Scope and disclosures Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication. Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases. Reviewed for accuracy by a board-certified physician (DO).